S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
NASDAQ:BBH

VanEck Vectors Biotech ETF News Headlines

$160.74
+5.67 (+3.66%)
(As of 01/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$153.77
$160.74
50-Day Range
$155.07
$198.48
52-Week Range
$153.39
$222.22
Volume
42,133 shs
Average Volume
34,849 shs
Market Capitalization
$465.66 million
P/E Ratio
N/A
Dividend Yield
0.26%
Beta
0.82
Get VanEck Vectors Biotech ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

VanEck Vectors Biotech ETF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BBH
News Sentiment

0.00

0.31

Average
Finance
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BBH Articles
This Week

0

0

BBH Articles
Average Week



VanEck Vectors Biotech ETF (NASDAQ:BBH) News Headlines Today

SourceHeadline
MarketBeat logoVanEck Vectors Biotech ETF (NASDAQ:BBH) Sees Strong Trading Volume
americanbankingnews.com - January 13 at 12:02 PM
finance.yahoo.com logoBest Biotech ETFs for Q1 2022
finance.yahoo.com - December 23 at 8:29 PM
247wallst.com logoBiotech Has Been Crushed: 5 Stocks to Buy Now That Pay Big Dividends
247wallst.com - December 9 at 9:45 AM
nasdaq.com logoBet on BBH for Biotechnology Bounce Back
nasdaq.com - December 8 at 6:16 PM
nasdaq.com logoMemeification of Biotech Stocks Shines Light on This ETF
nasdaq.com - November 24 at 5:32 PM
finance.yahoo.com logoBest Biotech ETFs for Q4 2021
finance.yahoo.com - August 12 at 3:58 PM
nasdaq.com logoMostly Sanguine Regulatory Outlook for Biotech, Healthcare Names
nasdaq.com - July 30 at 11:33 PM
nasdaq.com logoModerna Soars on Inclusion to S&P 500: ETFs in Focus
nasdaq.com - July 19 at 2:48 PM
msn.com logoHow Will Biotech ETFs React to These Q1 Earnings Releases?
msn.com - May 6 at 7:10 PM
nasdaq.com logoBiotech ETFs Make Gains Tuesday, Despite the J&J Vaccine Pause
nasdaq.com - April 13 at 7:51 PM
marketwatch.com logoHow to Improve The Timing of Investment Decisions in Van Eck Vectors Biotech Etf $BBH
marketwatch.com - March 24 at 10:47 AM
nasdaq.com logoBiotech Shined with Vaccines. It Can Do It Again with ‘BBH’
nasdaq.com - March 3 at 4:23 PM
nasdaq.com logoIllumina Earnings, Forward Guidance Strengthen Biotech ETFs
nasdaq.com - February 12 at 5:26 PM
nasdaq.com logoIPOs Are Back. Get In On the Action with the BBH ETF
nasdaq.com - February 9 at 2:51 PM
nasdaq.com logoNovavax (NVAX) ETFs to Rise on Impressive Coronavirus Vaccine Update
nasdaq.com - January 29 at 5:29 PM
nasdaq.com logoBiotech Surge – COVID-19 Cure is Just the Start
nasdaq.com - January 3 at 9:10 AM
nasdaq.com logoBullish on Biotech? The BBH ETF is Not Just a 2020 Play
nasdaq.com - November 19 at 5:14 PM
nasdaq.com logoVanEck Vectors Biotech ETF (BBH)
nasdaq.com - October 29 at 5:57 PM
finance.yahoo.com logoLate-Stage Coronavirus Vaccine Trials Begin: Biotech ETFs to Gain
finance.yahoo.com - July 28 at 3:21 PM
www.nasdaq.com logoBiotech ETFs to Shine on Pfizer's Coronavirus Vaccine Progress
www.nasdaq.com - July 14 at 7:07 PM
www.nasdaq.com logoBiotech ETFs to Gain as Coronavirus Vaccine Hopes Strengthen
www.nasdaq.com - July 3 at 12:33 PM
finance.yahoo.com logoNew Pharma ETF Focuses on Testing and Treatment for Infectious Diseases--but Not Covid-19
finance.yahoo.com - June 28 at 5:18 PM
www.nasdaq.com logoRace for Coronavirus Vaccine Heats Up: Biotech ETFs to Gain
www.nasdaq.com - May 27 at 12:35 PM
finance.yahoo.com logoBiotech ETFs Poised to Benefit From Coronavirus
finance.yahoo.com - May 7 at 5:54 AM
finance.yahoo.com logoBiotech Stocks & ETFs to Gain on Progress in COVID-19 Vaccine Development
finance.yahoo.com - April 1 at 10:10 PM
www.nasdaq.com logoVanEck Vectors Biotech ETF (BBH) After-Hours Quotes
www.nasdaq.com - February 12 at 7:24 PM
www.nasdaq.com logoVanEck Vectors Biotech ETF (BBH) Real-Time Quotes
www.nasdaq.com - February 12 at 7:24 PM
www.msn.com logoCan Biotech ETFs Gain on Mixed Q4 Earnings Results?
www.msn.com - February 11 at 6:10 PM
finance.yahoo.com logoVAREX IMAGING (VREX) Q1 Earnings Miss Estimates
finance.yahoo.com - February 11 at 6:10 PM
www.msn.com logoThe Top Biotech ETFs to Watch in 2020
www.msn.com - January 3 at 3:06 PM
seekingalpha.com logoVanEck Vectors Biotech ETF declares annual distribution of $0.4724
seekingalpha.com - December 20 at 11:37 PM
seekingalpha.com logoVanEck Vectors Biotech ETF declares annual distribution of $0.4160
seekingalpha.com - November 27 at 5:51 PM
www.thestreet.com logoVanEck Vectors Biotech ETF
www.thestreet.com - March 19 at 3:46 PM
seekingalpha.com logoBiotech Is Worth The Hype, But Do You Have The Data?
seekingalpha.com - March 2 at 3:31 PM
247wallst.com logoWhy 6 Top Biotech Stocks Could Beat Wall Street Q4 Estimates
247wallst.com - January 31 at 9:33 AM
finance.yahoo.com logoBristol-Myers to Acquire Celgene: Healthcare ETFs in Focus
finance.yahoo.com - January 4 at 3:23 PM
Get VanEck Vectors Biotech ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.